Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-022-00888-1, published online 09 March 2022
In the process of collating the raw data, the authors noticed an inadvertent mistake occurred in Fig. 3b that needs to be corrected after online publication of the article.
In Fig. 3b, as a result of an error in the graphics panel arrangement process, the band of NEMO was repeatedly inserted as β-actin by mistake. The correct band is shown as below and in the updated Fig. 3b. The correction did not affect any of our results or discussion as present in the original publication. We regret any inconvenience this has caused.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yu, Z., Gao, J., Zhang, X. et al. Correction: Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth. Sig Transduct Target Ther 8, 330 (2023). https://doi.org/10.1038/s41392-023-01618-x
Published:
Version of record:
DOI: https://doi.org/10.1038/s41392-023-01618-x
